Sarepta Therapeutics Inc. (NASDAQ:SRPT) has received a consensus rating of “Buy” from the twenty ratings firms that are presently covering the company. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation, thirteen have issued a buy recommendation and one has given a strong buy recommendation to the […]
